Copyright
©The Author(s) 2024.
World J Diabetes. Jul 15, 2024; 15(7): 1489-1498
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1489
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1489
Figure 1 Flow diagram of patient screening.
T2DM: Type 2 diabetes; IA: Insulin antibody; GADAb: Glutamic acid decarboxylase antibody.
- Citation: Zhang P, Jiang Q, Ding B, Yan RN, Hu Y, Ma JH. Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes. World J Diabetes 2024; 15(7): 1489-1498
- URL: https://www.wjgnet.com/1948-9358/full/v15/i7/1489.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i7.1489